Search

Your search keyword '"Jiang, Xiangyan"' showing total 33 results

Search Constraints

Start Over You searched for: Author "Jiang, Xiangyan" Remove constraint Author: "Jiang, Xiangyan"
33 results on '"Jiang, Xiangyan"'

Search Results

2. Neoadjuvant cadonilimab plus FLOT chemotherapy in locally advanced gastric/gastroesophageal junction adenocarcinoma: A multicenter, phase 2 study

Catalog

Books, media, physical & digital resources

6. Preparation and characterization study of composite dust suppressant based on xanthan gum.

7. PANoptosis in Bacterial Infections: A Double-Edged Sword Balancing Host Immunity and Pathogenesis.

8. Gastric cancer-derived exosomal let-7 g-5p mediated by SERPINE1 promotes macrophage M2 polarization and gastric cancer progression.

13. Data from PICH Activates Cyclin A1 Transcription to Drive S-Phase Progression and Chemoresistance in Gastric Cancer

14. Supplementary Data from PICH Activates Cyclin A1 Transcription to Drive S-Phase Progression and Chemoresistance in Gastric Cancer

17. PICH activates Cyclin A1 transcription to drive S-phase progression and chemoresistance in gastric cancer.

19. Therapeutic strategies targeting uPAR potentiate anti–PD-1 efficacy in diffuse-type gastric cancer

21. A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination

22. Allusivity or Explicit-Implicit Comparison: A Critical Review of the Tradition of Francois Jullien's Indirect Writing.

24. Chromatographic Analysis of Nitrogen Utilization and Transport in Arbuscular Mycorrhizal Fungal Symbiosis

25. Neoadjuvant sintilimab and apatinib combined with perioperative FLOT chemotherapy for locally advanced gastric cancer: a prospective, single-arm, phase II study

27. Biological Functions and Therapeutic Potential of UBE2T in Human Cancer.

28. KRAS G12D -driven pentose phosphate pathway remodeling imparts a targetable vulnerability synergizing with MRTX1133 for durable remissions in PDAC.

29. Mechanisms of Anti-PD Therapy Resistance in Digestive System Neoplasms.

30. Targeting SHCBP1 Inhibits Tumor Progression by Restoring Ciliogenesis in Ductal Carcinoma.

31. Targeting NUF2 suppresses gastric cancer progression through G2/M phase arrest and apoptosis induction.

32. Targeted Mevalonate Pathway and Autophagy in Antitumor Immunotherapy.

33. Research progress in Lamins in malignant tumors.